Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy
Crossref DOI link: https://doi.org/10.1007/s00280-014-2562-1
Published Online: 2014-08-09
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Zheng
Qing, Yi
Guan, Wei
Li, Mengxia
Peng, Yu
Zhang, Shiheng
Xiong, Yanli
Wang, Dong
Text and Data Mining valid from 2014-08-09